乳腺疾病病理标本的微血管检测

[1] Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Horak ER,Leek R,Klenk N,et al. The Lancet . 1992

[2] Angiogenesis and risk of breast cancer in women with fibrocystic disease. Guinebretiere JM,Le Monique G,Gavoille A,et al. Journal of the National Cancer Institute . 1994

[3] 乳癌中微血管活性检测的意义 [J]. 国外医学外科学分册., 1998, (06) : 344 - 347

[4] Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. Gasparini G,Harris A. Journal of Clinical Oncology . 1995

[1] Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Horak ER,Leek R,Klenk N,et al. The Lancet . 1992

[2] Angiogenesis and risk of breast cancer in women with fibrocystic disease. Guinebretiere JM,Le Monique G,Gavoille A,et al. Journal of the National Cancer Institute . 1994

[3] 乳癌中微血管活性检测的意义 [J]. 国外医学外科学分册., 1998, (06) : 344 - 347

[4] Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. Gasparini G,Harris A. Journal of Clinical Oncology . 1995